Evidence map›Paper›PMID 40430455›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Newly Started Versus Previously Treated Statin Patients: A Retrospective Cohort Study Comparing Adherence and Persistence with Reference to Cardiovascular Prevention.

Marta Martín-Fernández, M Asunción González-González, M Aránzazu Pedrosa-Naudín, Diego Fernández-Lázaro, F Javier Álvarez, Eduardo Gutiérrez-Abejón

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marta Martín-FernándezPharmacological Big Data Laboratory, Department of Cell Biology, Genetics, Histology and Pharmacology, Faculty of Medicine, University of Valladolid, 47003 Valladolid, Spain.
M Asunción González-GonzálezPharmacy Directorate, Castilla y León Health Council, 47007 Valladolid, Spain.
M Aránzazu Pedrosa-NaudínPharmacy Directorate, Castilla y León Health Council, 47007 Valladolid, Spain.
Diego Fernández-LázaroArea of Histology and Neurobiology Research Group, Faculty of Medicine, University of Valladolid, 47003 Valladolid, Spain.ORCID 0000-0002-6522-8896
F Javier ÁlvarezPharmacological Big Data Laboratory, Department of Cell Biology, Genetics, Histology and Pharmacology, Faculty of Medicine, University of Valladolid, 47003 Valladolid, Spain.ORCID 0000-0002-7566-5678
Eduardo Gutiérrez-AbejónPharmacological Big Data Laboratory, Department of Cell Biology, Genetics, Histology and Pharmacology, Faculty of Medicine, University of Valladolid, 47003 Valladolid, Spain.ORCID 0000-0003-2612-934X

Funding

Gerencia Regional de Salud de Castilla y León (Spain) GRS 2778/C/2023
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adherencecardiovascular preventiondrug utilizationHMG-CoA reductaseinhibitorspersistencestatins

Identifiers

PMID40430455
PMCPMC12114615

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.